Position in BNTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$354,706
-$98,226 QoQ
Shares Held
3,812
-25.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#166
of 282 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. BNTX ranks #73 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in BNTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $354,706 | 3,812 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $452,932 | 5,096 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $424,972 | 4,464 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $353,454 | 3,584 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $397,133 | 3,730 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $408,677 | 4,488 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $530,095 | 4,652 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $688,034 | 5,793 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $486,419 | 6,053 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $625,916 | 6,785 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $648,859 | 6,148 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $663,573 | 6,108 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $653,084 | 6,051 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $807,587 | 6,483 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $1,142,573 | 7,606 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $999,865 | 7,413 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,023,273 | 6,863 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,555,507 | 9,120 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,198,782 | 12,408 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,793,158 | 17,558 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,190,066 | 14,249 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,134,484 | 10,390 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $834,683 | 10,239 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||